Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05795036 · ClinicalTrials.gov registry record · NA
Using a mHealth Intervention to Promote Physical Activity in Phase III Cardiac Rehabilitation Clients
A NA study of Physical Activity and Cardiac Rehabilitation, sponsored by AdventHealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT05795036: Recruiting NA study of Physical Activity and Cardiac Rehabilitation, sponsored by AdventHealth University.
NCT05795036 is a NA study of Physical Activity and Cardiac Rehabilitation that is actively recruiting participants, run by AdventHealth University. The registered enrollment target is 46 participants, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05795036, a NA study of Physical Activity and Cardiac Rehabilitation, is actively recruiting participants, sponsored by AdventHealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators will implement a pilot project of using activity tracker (i.e., Fitbit) with phase III CR clients. The study will record the participants' daily steps and sleep patterns for 8 consecutive weeks in natural settings. Two specific aims are identified for this project: 1. Develop an intervention protocol using mHealth to promote Phase III CR clients' self-monitoring of PA. 2. Examine the efficacy of the intervention on clients' PA, sleep patterns, functional capacity and QoL.
Conditions Studied
Interventions
- DEVICE mHealth 1
- DEVICE mHealth 2
Study Locations (1)
Florida
- AdventHealth University - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2025-12-17 |
| Phase | NA |
What NCT05795036 shows while recruiting
NCT05795036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 358-participant average among 131 other Physical Activity trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Physical Activity appearing as the primary indexed condition, and to 2 interventions - of which mHealth 1 is the first listed.
NCT05795036 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05795036 about?
NCT05795036 is a clinical study titled "Using a mHealth Intervention to Promote Physical Activity in Phase III Cardiac Rehabilitation Clients". In this study, the investigators will implement a pilot project of using activity tracker (i.e., Fitbit) with phase III CR clients. The study will record the participants' daily steps and sleep patterns for 8 consecutive weeks in natural settings. Two specific aims are identified for this project: ...
What is the current status of trial NCT05795036?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2023-02-17. Estimated completion is 2025-12-17.
What conditions does trial NCT05795036 study?
This clinical trial studies the following conditions: Physical Activity, Cardiac Rehabilitation.
What interventions are being tested in trial NCT05795036?
The interventions under investigation include: mHealth 1 (DEVICE), mHealth 2 (DEVICE).
Who is sponsoring clinical trial NCT05795036?
This trial is sponsored by AdventHealth University, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05795036 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Physical Activity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05795036's enrollment target sits among peer trials
46 102nd of 131 higher than 30 of 131 other Physical Activity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Physical Activity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Va Meh Du: A Sports-based Mental Health Promotion Intervention for Karenni Refugees
RECRUITING · NA
-
Teen Mom Study Feasibility Trial
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI